<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15562">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02904291</url>
  </required_header>
  <id_info>
    <org_study_id>2016/1145</org_study_id>
    <nct_id>NCT02904291</nct_id>
  </id_info>
  <brief_title>Bariatric Surgery and Pharmacokinetics of Medication</brief_title>
  <acronym>BAR-MEDS</acronym>
  <official_title>BAR-MEDS: Bariatric Surgery and Pharmacokinetics of Medication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bariatric surgery changes the anatomy of the gastro-intestinal tract. Little is yet known
      about how the patients' new physiology may alter the pharmacokinetics of medication. Changes
      in biological availability of medication may have implications for the patients' health in
      the years following surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2026</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Area under curve (AUC)</measure>
    <time_frame>From baseline to 1year postoperatively</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Obesity, Morbid</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Patients are tested for their normal prescription medications</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for bariatric surgery (gastric bypass or sleeve gastrectomy)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway

          -  Being a Norwegian citizen

        Exclusion Criteria:

          -  Having previously undergone resections in the GI-tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnus Strømmen, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Olavs University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magnus Strømmen, MSc</last_name>
    <email>magnus.strommen@stolav.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Olavs University Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magnus Strømmen, MSc</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 13, 2016</lastchanged_date>
  <firstreceived_date>September 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bariatric surgery</keyword>
  <keyword>Gastrointestinal tract</keyword>
  <keyword>Biological availability</keyword>
  <keyword>Pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
